clevidipine has been researched along with alprenolol in 1 studies
Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
---|---|---|---|---|---|
127 | 19 | 62 | 1,146 | 121 | 59 |
Protein | Taxonomy | clevidipine (IC50) | alprenolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for clevidipine and alprenolol
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |